How Much Does Enhertu Cost?
Enhertu (Fam-Trastuzumab Deruxtecan) costs an average of $16,930 per Medicare Part D claim, with total Medicare spending of $1456.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $16,930 |
| Total Medicare Spending | $1456.0M |
| Total Claims | 86,000 |
| Beneficiaries | 9,600 |
| Generic Available | Yes |
| Year-Over-Year Change | +125.4% |
Enhertu (Fam-Trastuzumab Deruxtecan) costs an average of $16,930 per Medicare Part D claim, with total Medicare spending of $1456.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.